-
Mashup Score: 0Cost-Effectiveness of Catheter Ablation Versus Antiarrhythmic Drug Therapy in Atrial Fibrillation: The CABANA Randomized Clinical Trial - 2 year(s) ago
BACKGROUND: In the CABANA trial (Catheter Ablation vs Antiarrhythmic Drug Therapy for Atrial Fibrillation), catheter ablation did not significantly reduce the primary end point of death, disabling st
Source: CirculationCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 14
Compared with drug therapy, there was age-based variation in catheter ablation clinical outcomes among patients with atrial fibrillation, with the largest benefits observed in younger patients, according to new data from the CABANA trial.“The CABANA trial was the first large prospective randomized trial with extended follow-up to compare catheter ablation to drug therapy with regard to
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 9Association Between Age and Outcomes of Catheter Ablation Versus Medical Therapy for Atrial Fibrillation: Results from the CABANA Trial - 2 year(s) ago
Background: Observational data suggest catheter ablation may be safe and effective to treat younger and older patients with atrial fibrillation (AF). No large randomized trial has examined this issue
Source: CirculationCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2Ablation Versus Drug Therapy for Atrial Fibrillation in Racial and Ethnic Minorities: - 3 year(s) ago
Abstract Background Rhythm control strategies for atrial fibrillation (AF), including catheter ablation, are substantially underused in racial/ethnic minorities in North America. Objectives This st…
Categories: Healthcare Professionals, Latest HeadlinesTweet-
@JACCJournals @PittGIM @UPMC @PittDeptofMed @PittHealthSci @PittPubHealth @PittCP3 @diversity_updom @UPMCnews @PittIMChiefs @vaequity Our letter was in response to really fascinating findings led by @KLThomasMD examining the #CABANA trial. Take a look if you haven't already. 👇🏾 🙏🏾 my co-authors @jared_w_magnani and 🌟 resident & your fave future cardiologist @DrTertulien. Link: https://t.co/StO69wOdqr 3/3 https://t.co/XSkxTfakWG
-
-
Mashup Score: 1CABANA: AF ablation potentially superior to drug therapy among underrepresented groups - 3 year(s) ago
Patients from underrepresented racial and ethnic groups benefited significantly from catheter ablation compared with drug therapy for the treatment of atrial fibrillation, according to new data from the CABANA trial.The researchers also found that, among patients who were randomly assigned to drug therapy for AF, major adverse events were more prevalent among individuals from historically
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1The Cabana Trial and Heart Failure - 3 year(s) ago
Article, see p 1954Trials such as CASTLE-AF (Catheter Ablation Versus Standard Conventional Therapy in Patients With Left Ventricular Dysfunction and Atrial Fibrillation), AATAC (Ablation Versus Amiodarone for Treatment of Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted ICD/CRTD), and AMICA (Atrial Fibrillation Management in Congestive Heart Failure With Ablation),…
Source: CirculationCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1
Background: In patients with heart failure and atrial fibrillation (AF), several clinical trials have reported improved outcomes, including freedom from AF recurrence, quality of life, and survival,
Source: CirculationCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Written by Douglas P Zipes MD
Source: PracticeUpdateCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 4Effect of Catheter Ablation vs Medical Therapy on Quality of Life in Patients With Atrial Fibrillation - 4 year(s) ago
This open-label randomized trial compares the effect of pulmonary vein isolation via catheter ablation vs rate and rhythm control using drug therapy on the quality of life of patients with atrial fibrillation.
Source: jamanetwork.comCategories: CardiologistsTweet
#OriginalResearch: For #CABANA‐eligible pts with symptomatic #Afib, #ablation increases the quality‐adjusted life expectancy vs drug therapy alone for an increased cost within present benchmarks for good value in the US @derek_c1 @jonpiccinisr @DanMarkMD https://t.co/FOMsC9JgYE https://t.co/ZkHzdz3AUm